Asure Software to Attend 26th Annual Needham Growth Conference
AUSTIN, Texas, Jan. 05, 2024 (GLOBE NEWSWIRE) — Asure Software, Inc. (Nasdaq: ASUR), an established provider of cloud-based Human Capital […]
First ReWalk Personal Exoskeleton Claim Paid by Medicare
MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILLIT, Israel, Jan. 05, 2024 (GLOBE NEWSWIRE) — ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk”), […]
Midland States Bancorp, Inc. to Announce Fourth Quarter 2023 Financial Results on Thursday, January 25
EFFINGHAM, Ill., Jan. 05, 2024 (GLOBE NEWSWIRE) — Midland States Bancorp, Inc. (NASDAQ: MSBI) announced today that it will issue […]
Hurco Reports Fourth Quarter and Full Year Results for Fiscal 2023
INDIANAPOLIS, Jan. 05, 2024 (GLOBE NEWSWIRE) — Hurco Companies, Inc. (Nasdaq: HURC) today reported results for the fourth fiscal quarter […]
Genetic Technologies Regains Compliance with Nasdaq Minimum Bid Price Requirement
MELBOURNE, Australia, Jan. 05, 2024 (GLOBE NEWSWIRE) — Genetic Technologies Limited (NASDAQ: GENE, “Company”) a global leader in genomics-based tests […]
WiMi Announced Image-Fused Point Cloud Semantic Segmentation with Fusion Graph Convolutional Network
Beijing, Jan. 05, 2024 (GLOBE NEWSWIRE) — WiMi Hologram Cloud Inc. (NASDAQ: WIMI) (“WiMi” or the “Company”), a leading global […]
Lifecore Biomedical Expands Relationship with Existing Long-Term Customer Through a Series of Commercial Arrangements
Lifecore enters into commercial agreements with Alcon that include new 8-year commercial manufacturing arrangements Lifecore receives amendment and waiver for […]
Silicon Motion Announces Preliminary Fourth Quarter 2023 Revenue and Earnings Conference Call Details
TAIPEI, Taiwan and MILPITAS, Calif., Jan. 05, 2024 (GLOBE NEWSWIRE) — Silicon Motion Technology Corporation (NasdaqGS: SIMO) (“Silicon Motion” or […]
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif., Jan. 05, 2024 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel […]
DZS Secures $25 Million in Funding and Signs Definitive Agreement to Divest Asia Business
DALLAS, Jan. 05, 2024 (GLOBE NEWSWIRE) — DZS (Nasdaq: DZSI), a global leader of access, optical and AI-driven cloud software […]
